Danish Cancer Society Research Center, Copenhagen, Denmark.
University of Oklahoma Health Sciences Center, Oklahoma City, OK.
J Natl Cancer Inst. 2018 May 1;110(5):534-538. doi: 10.1093/jnci/djx248.
To examine whether cancer survivors diagnosed before age 35 years are more likely to have offspring with chromosomal abnormalities than their siblings, chromosomal abnormalities were determined in a population-based cohort of 14 611 offspring (14 580 live-born children and 31 fetuses) of 8945 Danish cancer survivors and 40 859 offspring (40 794 live-born children and 65 fetuses) of 19 536 siblings. Chromosomal abnormalities include numeric and structural abnormalities. Odds ratios were estimated by multiple logistic regression models comparing the risk of chromosomal abnormalities among survivors' offspring with that in siblings' offspring. In a subgroup of survivors with gonadal radiation doses (mean = 0.95 Gy for males and 0.91 Gy for females), no indication of a dose response was found. Overall, no increased risk of chromosomal abnormalities among survivors' offspring was observed compared with their siblings' offspring (odds ratio = 0.99, 95% confidence interval = 0.67 to 1.44, two-sided P = .94), with similar risk between male and female survivors. Cancer survivors were not more likely than their siblings to have children with a chromosomal abnormality.
为了研究 35 岁以下被诊断患有癌症的幸存者与他们的兄弟姐妹相比,其后代更有可能出现染色体异常,我们在一个基于人群的队列中研究了 14611 名后代(14580 名活产儿和 31 名胎儿),这些后代是 8945 名丹麦癌症幸存者和 40859 名后代(40794 名活产儿和 65 名胎儿)的兄弟姐妹。染色体异常包括数目和结构异常。通过比较幸存者后代和兄弟姐妹后代的染色体异常风险,使用多逻辑回归模型估计比值比。在有性腺辐射剂量的幸存者亚组中(男性平均剂量为 0.95Gy,女性平均剂量为 0.91Gy),未发现剂量反应的迹象。总体而言,与兄弟姐妹的后代相比,幸存者的后代没有观察到染色体异常风险增加(比值比=0.99,95%置信区间为 0.67 至 1.44,双侧 P=0.94),男性和女性幸存者之间的风险相似。癌症幸存者与他们的兄弟姐妹相比,他们的孩子没有更有可能出现染色体异常。